Company Profile

Intelligent Medical Devices LLC (AKA: IMDx~ntelligentMDx,)
Profile last edited on: 6/15/21      CAGE: 6YTC0      UEI:

Business Identifier: Molecular diagnostics
Year Founded
2000
First Award
2003
Latest Award
2004
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

58 Charles Street
Cambridge, MA 02141
   (617) 871-6400
   N/A
   www.intelligentmd.com
Location: Single
Congr. District: 07
County: Middlesex

Public Profile

IIntelligent Medical Devices LLC - aka MDx - was founded out of an underserved need in the industry: rapid and effective diagnostics to shrink the turnaround time between a patient presenting with an illness and a prescribed targeted treatment. As the IVD diagnostics space shifts from widely accepted, traditional culture methods, to highly sensitive and specific molecular methods, IMDx is uniquely positioned to make a difference in global healthcare. A privately held company based in Waltham, MA, IMDx employs experts from diverse backgrounds including financial, legal, quality, scientific, and medical, and is run in a unique manner such that all are involved in shaping products from concept stage to commercialization. IMDx has been named a Business Leader in Medical Diagnostics by Scientific American magazine within the Scientific American 50 and has been granted a North American Healthcare Innovation Award in molecular diagnostics by Frost & Sullivan.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
50-74
Revenue Range
5M-7.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
20-24

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2004 1 NIH $94,137
Project Title: Multiplex Prenatal Screen for Perinatal Pathogens
2003 1 NIH $99,806
Project Title: Simultaneous Detection of Common Respiratory Viruses

Key People / Management

  Alice Jacobs Nesselrodt -- Founder and CEO

  David L Dolinger -- VP of R&D

  James R Hully

  Heather L Kiefer

  Michael Paquette -- Senior Director of Operations

Company News

There are no news available.